UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.153

Sortiert nach

Cabozantinib in Progressive Medullary Thyroid Cancer

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3639-3646

2013

Link zum Volltext

Verfügbarkeit prüfen

Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2

PloS one, 2016-10, Vol.11 (10), p.e0163648-e0163648

2016

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer

Cancers, 2024-02, Vol.16 (5), p.886

2024

Link zum Volltext

Verfügbarkeit prüfen

Improved Regional Activity Quantitation in Nuclear Medicine Using a New Approach to Correct for Tissue Partial Volume and Spillover Effects

IEEE transactions on medical imaging, 2012-02, Vol.31 (2), p.405-416

2012

Link zum Volltext
IEEE_Xplore

Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial

European journal of cancer (1990), 2020-01, Vol.124, p.25-36

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

Cancer medicine (Malden, MA), 2020-11, Vol.9 (22), p.8386-8396

2020

Link zum Volltext

Verfügbarkeit prüfen

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method

The Journal of nuclear medicine (1978), 2021-01, Vol.62 (1), p.37-42

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial

Journal of cancer research and clinical oncology, 2022-10, Vol.148 (10), p.2611-2621

2022

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36]

European journal of cancer (1990), 2020-09, Vol.136, p.207-208

2020

Link zum Volltext

Verfügbarkeit prüfen

Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1372-1379

2020

Link zum Volltext

Verfügbarkeit prüfen

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV max Method

Journal of Nuclear Medicine, 2021-01, Vol.62 (1), p.37-42

2021

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer

European journal of nuclear medicine and molecular imaging, 2017-02, Vol.44 (2), p.242-246

2017

Link zum Volltext

Verfügbarkeit prüfen

The Treatment of Well-Differentiated Thyroid Carcinoma

Deutsches Ärzteblatt international, 2015-06, Vol.112 (26), p.452-458

2015

Link zum Volltext

Verfügbarkeit prüfen

MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data

European journal of nuclear medicine and molecular imaging, 2008-06, Vol.35 (6), p.1142-1146

2008

Link zum Volltext

Verfügbarkeit prüfen

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

Hematological oncology, 2020-08, Vol.38 (3), p.244-256

2020

Link zum Volltext

Verfügbarkeit prüfen

Performance of a high-sensitivity dedicated cardiac SPECT scanner for striatal uptake quantification in the brain based on analysis of projection data

Medical physics (Lancaster), 2013-04, Vol.40 (4), p.042504-n/a

2013

Link zum Volltext

Verfügbarkeit prüfen

Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer

European radiology, 2007-12, Vol.17 (12), p.3139-3147

2007

Link zum Volltext

Verfügbarkeit prüfen

Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination

Data in brief, 2020-02, Vol.28, p.104976-104976, Article 104976

2020

Link zum Volltext

Verfügbarkeit prüfen

Subjective perceptions of patients undergoing radioiodine therapy: why should we know about them?

European journal of nuclear medicine and molecular imaging, 2009-11, Vol.36 (11), p.1743-1744

2009

Link zum Volltext

Verfügbarkeit prüfen

Positron emission tomography/computed tomography–imaging protocols, artifacts, and pitfalls

Molecular Imaging and Biology, 2004-07, Vol.6 (4), p.188-199

2004

Link zum Volltext

Verfügbarkeit prüfen

Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows

European journal of nuclear medicine and molecular imaging, 2005-12, Vol.32 (12), p.1429-1439

2005

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the human cerebellum during habituation of the acoustic startle response: A PET study

Journal of neurology, neurosurgery and psychiatry, 1998-11, Vol.65 (5), p.771-773

1998

Link zum Volltext

Verfügbarkeit prüfen

Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer

Nuclear medicine communications, 2006-08, Vol.27 (8), p.669-676

2006

Link zum Volltext

Verfügbarkeit prüfen

Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET

European journal of nuclear medicine and molecular imaging, 2008-03, Vol.35 (3), p.502-508

2008

Link zum Volltext

Verfügbarkeit prüfen

Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial: Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale

Blood, 2018-11, Vol.132 (Supplement 1), p.1696-1696

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.010)
Mit Volltextzugriff
(989)

Publikationsform

Sprache

Englisch
(1.079)
Japanisch
(172)
Deutsch
(68)
Norwegisch
(5)
Russisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(18)
Nature Genetics
(15)
Plos One
(13)
The Journal Of Biological Chemistry
(13)
The Journal Of Urology
(13)
The New England Journal Of Medicine
(12)
Angewandte Chemie
(11)
Nature Communications
(10)
European Heart Journal
(9)
Science
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Cabozantinib in Progressive Medullary Thyroid Cancer

Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2

Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer

Improved Regional Activity Quantitation in Nuclear Medicine Using a New Approach to Correct for Tissue Partial Volume and Spillover Effects

Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method

Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial

Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36]

Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV max Method

Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer

The Treatment of Well-Differentiated Thyroid Carcinoma

MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

Performance of a high-sensitivity dedicated cardiac SPECT scanner for striatal uptake quantification in the brain based on analysis of projection data

Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer

Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination

Subjective perceptions of patients undergoing radioiodine therapy: why should we know about them?

Positron emission tomography/computed tomography–imaging protocols, artifacts, and pitfalls

Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows

Involvement of the human cerebellum during habituation of the acoustic startle response: A PET study

Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer

Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET

Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial: Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale

Suchergebnisse filtern